Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home
Patients & Consumers Health Professionals District Health Boards Pharmaceutical Suppliers

Wed Nov 25 2009 NZST

Search

2002

Prev, Next – Page 4 of 4 (40 documents)

icon

Expressions of interest for promotion of Responsible Use of Pharmaceuticals (6 pages, 44 KB)
2002/03/13

One of PHARMAC’s functions is to “promote the responsible use of pharmaceuticals” (section 48 (d) o the New Zealand Public Health and Disability Act 2000). PHARMAC is currently inviting external parties to provide expressions of interest (EOI) to provide services to promote the responsible use of pharmaceuticals for implementation from October 2002.

text


icon

National Hospital drug buying strategy agreed (2 pages, 66 KB)
2002/02/21
media, archive

Health Minister Annette King says a national pharmaceutical purchasing strategy will provide consistency and equitable access to hospital drugs throughout New Zealand. Ms King has approved the National Hospital Pharmaceutical Purchasing Strategy, which will see Pharmac, the Government’s drug-buying agency, authorised to work collaboratively with individual DHBs to purchase hospital drugs.

text


icon

Funding arrangements for beta-interferon for multiple sclerosis (MS) (1 page, 8 KB)
2002/02/07
consultation, archive

Consultation on funding arrangements for beta-interferon for multiple sclerosis (MS).

text


icon

Cochrane Chronic Asthma Review (133 pages, 813 KB)
2002/02/01

Background Beclomethasone dipropionate (BDP) and budesonide (BUD) are commonly prescribed inhaled corticosteroids for the treatment of asthma, Fluticasone propionate (FP) is newer agent with greater potency in in−vitro assays. Objectives: To compare the efficacy and safety of Fluticasone to Beclomethasone or Budesonide in the treatment of chronic asthma.

text


icon

Proposal for simvastatin (5 pages, 25 KB)
2002/02/01
consultation, archive

Further to our consultation letter of 24 December 2002, the following letter relates to: • the proposed prescribing guidelines…

text


icon

Statins Cost Utility Analysis (11 pages, 119 KB)
2002/02/01

Updated cost utility analysis for statins Scott Metcalfe Pharmac 30 January 2001 Pharmac estimates the cost-utility of providing statins to everyone with dyslipidaemia and > 10% 5-year absolute risk of cardiovascular events, at a proposed price of $0.45/day, is $1,630/QALY…

text


icon

Costs and Benefits of simvastatin 40mg vs fluvastatin 80mg treatment for patients with familial hyperlipidaemia (12 pages, 75 KB)
2002/01/31
archive

Purpose This paper examines the incremental benefits and costs of treating patients with familial hyperlipidaemia with simvastatin 40mg/day, over and above the net costs and…

text


icon

Methods and Assumptions - costs and benefits of lipid modifying agents (54 pages, 336 KB)
2002/01/31
archive

This paper describes a model which PHARMAC has developed to assess the costs and benefits of extending subsidy criteria for lipid-modifying agents (LMAs). The model assesses both need for…

text


icon

Summary - cost utility analysis of the lipid modifying agents (10 pages, 75 KB)
2002/01/31
archive

Net benefits of LMAs The benefits of LMAs can be measured in quality-adjusted life years saved (QALYS), which combine fatal with non-fatal events. Net quality-adjusted life years saved comprise: 1.…

text


Prev, Next – Page 4 of 4 (40 documents)

Search tips

Search or Browse

To search for a document enter a search term into the search form and activate the Search button.

Documents may be browsed by date, eg; Today, November, 2009.

Past years can be browsed too...
2008, 2007, 2006, 2005, 2004, 2003, 2002, 2001, 2000, 1999, 1998.

Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg;
Media releases from 2009

Search terms

Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.

Document tags (shown in bolded red below document date) have highest priority when search results are ranked, followed by title, abstract and full text of document (if available). Tags in use include...
AnnualReport, AnnualReview, archive, BIM, BoardPaper, BusinessPlan, CAC, CACminutes, consultation, delete, EC, ECForm, EOI, etender, herceptin, inpharmation, leaflet, media, notification, OIA, opinion, PatientGuide, policy, poster, PTAC, PTACminutes, PTACSCMinutes, Q&A, release, resource, RFI, RFP, SAForm, SAForms, schedule, SchedulePublications, SectionH, SOI, TAR, tender, update, vacancy, WhatsNew.

Documents with related dates can be browsed through the date component links below the document title.

Remember to group or statements with parentheses if they are beside and statements.

Search examples

consultation
Search for consultations
media and not antibiotics
Search for media related documents that don't mention antibiotics.
(media or consultation) and vaccines
Search for media releases and consultation documents mentioning vaccinations.